Position in PEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$127,247
-$2,469,831 QoQ
Shares Held
403
-94.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#341
of 446 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PEN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Employees Retirement System of Texas holds $188,239,981 across 12 Medical Devices names. PEN ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
193,102 | $60,796,233 | |
| 2 | MDT |
Medtronic plc
|
776,505 | $60,745,986 | |
| 3 | DXCM |
Dexcom Inc
|
538,893 | $36,294,443 | |
| 4 | EW |
Edwards Lifesciences Corp
|
199,455 | $18,042,699 | |
| 5 | BSX |
Boston Scientific Corp
|
149,437 | $6,377,971 | |
| 6 | ABT |
Abbott Laboratories
|
27,609 | $2,505,240 | |
| 7 | PODD |
Insulet Corp
|
8,342 | $1,270,069 | |
| 8 | GMED |
Globus Medical Inc
|
11,856 | $936,742 |
All Filings in PEN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,247 | 403 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,597,078 | 7,909 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,409,241 | 7,749 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,962,976 | 7,749 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,926,264 | 7,506 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,410,052 | 5,273 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,252,232 | 5,273 | Shares | Sole | 2025-02-28 | |
| 2024-09-30 | $777,045 | 3,999 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $719,700 | 3,999 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $892,496 | 3,999 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $484,717 | 1,927 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||